Company / Financials
Lipocine Inc. Financials
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$11.2M
FY2025 · +492.8% YoY
Net Income
$8.4K
FY2025 · +100.1% YoY
Profit Margin
0.1%
FY2025 · net income / revenue
ROE
0.0%
FY2025 · return on equity
Total Assets
$17.0M
FY2025
Total Debt
-
FY2025
Equity
$21.0M
FY2025
ROA
0.1%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -1.16 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$11.2M+492.8% YoYNet Income HistoryProfit after all expenses and taxes$8.4K+100.1% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$1.2M+93.6% YoYSG&A Expense HistorySelling, general, and administrative expenses$5.0M+2.0% YoYR&D Expense HistoryResearch and development spending$7.4M-27.7% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$681-9.8% YoYEPS (Basic) HistoryBasic earnings per share-$1.77+42.9% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$1.69+46.2% YoYShares Outstanding HistoryWeighted average diluted shares outstanding5.3M+0.6% YoY